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Background
The most common route for shunting in most countries is
now ventriculoperitoneal (VP). Reasons for switching
from ventriculoatrial (VA) to VP shunting include the
need for more revisions and the greater risk of infection in
VA shunts. While in the nosocomial setting healthcare
workers are very familiar with shunt problems, this might
give a skewed impression of their actual prevalence, and
the purposes of this survey were firstly to establish the sit-
uation regarding VP shunted people in the community
not currently receiving medical attention, and secondly to
compare them to those in our previous 2006 survey of
people with VA shunts.
Materials and methods
A randomly selected group of 405 people known to have
VP shunts from the ASBAH database were contacted with
a simple questionnaire containing five questions and
space for comments: Do you have a VP shunt? If so, for
how long have you had it? Have you ever had a VP shunt?
If so, how long did it last? Have you ever had problems
with your VP shunt such as blockage or infection? (if yes,
say what they were). The responses were then collated.
Results
Of the 405 people selected from the database, 128
responded. Eight were excluded from analysis (5 for insuf-
ficient data returned, 3 incorrectly entered – no VP shunt).
117 still had a VP shunt, and 3 now had a 3rd ventriculos-
tomy. Of those who still had a VP shunt, it had been in
place for a mean of 13.4 yrs (1 week to 40 yrs) compared
to 30.8 yrs (0.3–44 yrs) for VA. 43 people (35.8%)
reported no shunt problems (38% for VA). The VP infec-
tion rate per patient was 20% (12.75% for VA); VP
obstruction in 44% (48% for VA); VP catheter disconnec-
tions 13.7% (10% for VA). The rate of slit ventricles was
similar in each group (VP 4%, VA 2%). When the number
of shunt revisions was compared per patient shunt year,
there were 0.133 for VP, and 0.077 for VA.
Conclusion
Based on self – reporting, both VP and VA shunts appear
to perform better and for longer than expected based on
surveys and impressions from hospital patients. The rate
of some problems for VA and VP is similar, but there were
fewer infections and fewer revisions in VA shunts, con-
trary to popular expectation. These data are useful to
inform patients and carers, and surgeons who need to re-
site a shunt in case of repeated complications.
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